Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SHOCKWAVE MEDICAL, INC.

(SWAV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ShockWave Medical : Wells Fargo Adjusts Price Target on ShockWave Medical to $189 From $161, Maintains Overweight Rating

06/07/2021 | 08:18am EDT


ę MT Newswires 2021
All news about SHOCKWAVE MEDICAL, INC.
07/16SHOCKWAVE MEDICAL : SVB Leerink Starts ShockWave Medical at Outperform with $208..
MT
07/15SHOCKWAVE MEDICAL : to Report Second Quarter 2021 Financial Results on August 9,..
AQ
07/12SHOCKWAVE MEDICAL : BofA Securities Downgrades ShockWave Medical to Neutral From..
MT
06/29SHOCKWAVE MEDICAL, INC. : Submission of Matters to a Vote of Security Holders, F..
AQ
06/28SHOCKWAVE MEDICAL : Publications Validate Clinical Safety and Efficacy of Shockw..
AQ
06/28Shockwave Medical, Inc. Announces the Safety, Efficacy and Mechanism of Benef..
CI
06/18SHOCKWAVE MEDICAL : Wells Fargo Downgrades ShockWave Medical to Equal-Weight Fro..
MT
06/15SHOCKWAVE MEDICAL : Piper Sandler Adjusts ShockWave Medical's Price Target to $2..
MT
06/11SHOCKWAVE MEDICAL : Coronary Catheters Approved for Increased Medicare Payments
MT
06/11CMS Grants Transitional Pass-Through (TPT) Payment for Shockwave's Coronary I..
GL
More news
Financials (USD)
Sales 2021 201 M - -
Net income 2021 -53,1 M - -
Net cash 2021 125 M - -
P/E ratio 2021 -116x
Yield 2021 -
Capitalization 6 111 M 6 111 M -
EV / Sales 2021 29,7x
EV / Sales 2022 18,0x
Nbr of Employees 449
Free-Float 93,7%
Chart SHOCKWAVE MEDICAL, INC.
Duration : Period :
ShockWave Medical, Inc. Technical Analysis Chart | SWAV | US82489T1043 | MarketScreener
Technical analysis trends SHOCKWAVE MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 174,68 $
Average target price 193,00 $
Spread / Average Target 10,5%
EPS Revisions
Managers and Directors
Douglas Evan Godshall President, Chief Executive Officer & Director
Daniel Puckett Chief Financial officer & Secretary
Ray Larkin Chairman
Beaux Alexander Vice President-Clinical Affairs
W. Patrick Stephens Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
SHOCKWAVE MEDICAL, INC.68.42%6 790
NOVOCURE LIMITED9.44%22 880
MASIMO CORPORATION2.30%13 428
GETINGE AB88.13%10 566
PENUMBRA, INC.52.23%10 335
ASAHI INTECC CO., LTD.-22.26%6 227